Nasopharyngeal Extranodal NK/T-Cell Lymphoma,Nasal Type: Retrospective Study of 18 Consecutive Cases in Guangzhou,China

Abstract

Objective: The aim of this study was to investigate the frequency and clinicopathologic features of nasopharyngeal extranodal NK/T-cell lymphoma, nasal type (NKTCL), as well as DNA sequence variation of Epstein—Barr virus (EBV) in neoplastic cells harboring in NKTCLs from Guangzhou district. Materials and methods: The clinical data of 18 unselected consecutive nasopharyngeal NKTCLs in one institution were reviewed retrospectively. Immunohistochemical staining and EBV-encoded RNAs (EBERs) in situ hybridization were applied. DNA extraction, polymerase chain reaction (PCR), nested PCR, and sequencing for analyzing the C-terminal and N-terminal regions of LMP1 gene as well as BamHI F fragment of EBV were applied in 16 available samples. Results: NKTCLs accounted for 69.2% (18/26) of nasopharyngeal T- and NK-cell lineage non-Hodgkin lymphomas. In all, 10 out of 18 patients (55.56%) had cervical lymph node(s) involvement. The serum anti-EBV antibody level was elevated (VCA-IgA titer ≥1:40) in 6 of 12 available patients. Two major immunophenotypic subtypes, namely, TIA-1+/EBERs+/CD56+ (10 cases) and TIA-1+/EBERs+/CD56- (8 cases) could be recognized. Genotyping analysis revealed that 10 out of 13 cases (76.9%) of NKTCL were harbored with del-LMP1 [del-LMP1 (Gly335) variant 7 cases, del-LMP1 (Asp335) variant 3 cases]. XhoI-loss was shown in 8/11 cases (72.73%). BamHI “f” variant of Bam F fragment was shown only in 4/14 cases (28.57%).The most common combination was del-LMP1 (Gly335)/ XhoI-loss/F (6/9, 66.7%). Conclusions: The majority of nasopharyngeal T- and NK-cell lymphomas are NKTCL in Guangzhou district. The patients often have involvement of cervical lymph node(s) and an elevated level of serum anti-EBV antibodies. The CD56 expression rate seems lower than that found in sinonasal NKTCL. The most common EBV variant harboring in nasopharyngeal NKTCL seems somewhat different from that harboring in nasopharyngeal carcinoma in Guangzhou.

Keywords

nasopharyngeal lymphoma clinicopathologic features Epstein—Barr virus LMP1 gene BamHI F fragment

Get full access to this article

View all access options for this article.

References

Swerdlow SH , Campo E. , Harris NL , et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008:285-288.

Lung ML , Chang GC Detection of distinct Epstein-Barr virus genotypes in NPC biopsies from southern Chinese and Caucasians. Int J Cancer. 1992 ;52:34-37.

Lin SX , Zong YS , Zhang M. , et al. Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2005;34:791-795.

Lin JC , Lin SC , Luppi M. , et al. Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin’s lymphomas. J Med Virol. 1995;45:183-191.

Cheung MM , Chan JK , Lau WH , et al. Primary non-Hodgkin’s lymphoma of the nose and nasopharynx: clinical features,tumor immunophenotype, and treatment outcome in 113 patients . J Clin Oncol. 1998;16:70-77.

Menarguez J. , Mollejo M. , Carrion R. , et al. Waldeyer ring lymphomas. A clinicopathological study of 79 cases. Histopathology. 1994;24:13-22.

Ye YL , Zhou MH , Lu XY , Dai YR , Wu WX Nasopharyngeal and nasal malignant lymphoma: a clinicopathological study of 54 cases. Histopathology. 1992;20:511-516.

Barnes L. , Eveson JW , Reichart P. , Sidransky D. WHO Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. Lyon, France: IARC; 2005:104-105.

Laskar S. , Muckaden MA , Bahl G. , et al. Primary non-Hodgkin’s lymphoma of the nasopharynx: prognostic factors and outcome of 113 Indian patients. Leuk Lymphoma . 2006;47:2132-2139.

10.

Li YX , Coucke PA , Li JY , et al. Primary non-Hodgkin’s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy . Cancer. 1998;83:449-456.

11.

Pals ST , de Gorter DJ , Spaargaren M. Lymphoma dissemination: the other face of lymphocyte homing. Blood. 2007;110: 3102-3111.

12.

Feng YF , Wu QL , Zong YS Correlation of immunophenotype of sinonasal non-Hodgkin’s lymphoma to Epstein-Barr virus infection. Ai Zheng. 2007 ;26:1170-1176.

13.

Ng SB , Lai KW , Murugaya S. , et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004; 17:1097-1107.

14.

Takeshita M. , Yoshida K. , Suzumiya J. , et al. Cases of cutaneous and nasal CD56 (NCAM)-positivelymphoma in Japan have differences in immunohistology, genotype, and etiology. Hum Pathol. 1999;30:1024-1034.

15.

Ko YH , Ree HJ , Kim WS , et al. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer. 2000;89:2106-2116.

16.

Tai YC , Kim LH , Peh SC High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract. Pathol Int . 2004;54: 158-166.

17.

Kuo TT , Shih LY , Tsang NM Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol. 2004;12:375-387.

18.

Suzumiya J. , Ohshima K. , Takeshita M. , et al. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene. Leuk Lymphoma. 1999;35:567-578.

19.

Kim JE , Kim YA , Jeon YK , et al. Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1. Pathol Int. 2003;53:735-743.

20.

Chiang AK , Wong KY , Liang AC , et al. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/ NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy. Int J Cancer. 1999;80:356-364.

21.

Nagamine M. , Takahara M. , Kishibe K. , et al. Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma. Virus Genes. 2007;34:47-54.

22.

Zhou XG , Sandvej K. , Li PJ , et al. Epstein--Barr virus gene polymorphisms in Chinese Hodgkin’s disease cases and healthy donors: identification of three distinct virus variants . J Gen Virol. 2001;82:1157-1167.

23.

Cheung ST , Lo KW , Leung SF , et al. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer. 1996;66:711-712.

24.

Cheung ST , Leung SF , Lo KW , et al. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int J Cancer. 1998;76:399-406.

25.

Tang YL , Lu JH , Cao L. , et al. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes. Braz J Med Biol Res. 2008; 41:110-116.

26.

See HS , Yap YY , Yip WK , Seow HF Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and XhoI-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J Surg Oncol. 2008; 6:18.

27.

Han AJ , Zong YS , Zhang M. , et al. Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2003;32:534-538.

28.

Wu SJ , Lay JD , Chen CL , Chen JY , Liu MY , Su IJ Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area. J Med Virol. 1996;50: 314-321.